Войти в систему Зарегистрироваться бесплатно

Edesa Biotech Доход

Что обозначает Доход в Edesa Biotech?

Доход Edesa Biotech, Inc. является $0.00

Какое определение для Доход?



Доход - это прибыль, которую бизнес получает от обычной деловой деятельности, обычно от продажи товаров и предоставления услуг клиентам.

Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.

In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.

Доход компаний в Health Care сектор на NASDAQ по сравнению с Edesa Biotech

Что делает Edesa Biotech?

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.

Компании с доход похож на Edesa Biotech